ANNE SAUNIER: Open Payments
NPI 1528580164 · GRETNA, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$596 in 24 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $301 · 2025 $596
Food & beverage: $577Education: $19
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 6 | $152 |
| Lilly USA, LLC | 1 | $120 |
| ABBVIE INC. | 4 | $68 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $61 |
| Axsome Therapeutics, Inc. | 1 | $37 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| Astellas Pharma US Inc | 1 | $21 |
| Abbott Laboratories | 1 | $20 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
Products named: OTEZLA, MOUNJARO, TRINTELLIX, Auvelity, QULIPTA, VRAYLAR, AIRSUPRA, Veozah.
Industry payments across VA — which companies pay providers there.
